MM, don't care about what the company does, they just need to make sure there is trading volume. Shorties don't care either, they also make money on the volatility. I would hope karma meets up with them at some point, but unfortunately, if they are making money and the SEC doesn't give a cr@p about these small businesses, they will be laughing all the way to the bank until Cytosorbent hit critical mass/trading volume/market cap where it cannot be manipulated so easily.
News 
Market Data 
Discover 
AI
